MBNL3 Activators
MBNL3 activators encompass a group of specialized chemical agents that target the modulation of Muscleblind-like protein 3 (MBNL3), which is a member of the Muscleblind-like family of proteins. MBNL3 is implicated in the regulation of alternative splicing, a process essential for generating protein diversity from a single gene. The ability of MBNL3 to bind RNA and influence splicing events makes it a critical player in the post-transcriptional control of gene expression, impacting various aspects of cellular function.
The activation of MBNL3 can be attained through direct or indirect means. Direct activators may interact with the MBNL3 protein itself, enhancing its RNA-binding affinity or its interaction with other spliceosomal components, thus promoting its splicing regulatory activity. Such chemical activators could bind to specific domains within MBNL3, inducing a conformational shift that results in an increased splicing activity or a facilitation of its localization to the nucleus where splicing occurs. Indirect activators of MBNL3 might affect the protein's activity by modulating cellular signaling pathways that control the expression levels of MBNL3 or its post-translational state. These could be small molecules that stimulate the transcription of the MBNL3 gene, thereby raising the overall levels of the protein in the cell. Alternatively, they may activate or inhibit kinases or other enzymes that modify MBNL3 post-translationally, thereby affecting its splicing function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP is the primary energy molecule for cells and is a substrate for various kinase activities. ATP binding induces a conformational change in kinases, facilitating the phosphorylation of their substrates. Given that MBNL3 is a kinase, the presence of ATP can enhance MBNL3 activity by enabling it to phosphorylate its substrates. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, but at low concentrations, it can paradoxically enhance the activity of certain kinases. If MBNL3 behaves similarly, staurosporine may enhance its activity by promoting the binding of its substrates. | ||||||
Phosphatidyl-L-serine | 51446-62-9 | sc-507548 | 10 g | $46.00 | ||
Phosphatidylserine is a phospholipid that can bind to the C-terminal domain of certain kinases and enhance their activity by enabling the phosphorylation of their substrates. If MBNL3 has a similar binding site, phosphatidylserine could enhance its kinase activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels and activating PKA. PKA can phosphorylate and activate certain kinases. If MBNL3 is a downstream target of PKA, forskolin can enhance MBNL3 activity by promoting its phosphorylation by PKA. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, okadaic acid can enhance the activity of kinases by preventing the dephosphorylation of the active phosphorylated form. If MBNL3 is a substrate of these phosphatases, okadaic acid can enhance its activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A is an inhibitor of protein phosphatases PP1 and PP2A. It can enhance the activity of kinases by preventing the dephosphorylation of their phosphorylated form. If MBNL3 is a substrate of these phosphatases, calyculin A can enhance its activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor. It can indirectly enhance the activity of kinases by preventing the degradation of their phosphorylated form, thus maintaining their active state. If MBNL3 is regulated by proteasomal degradation, MG-132 can enhance its activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc pyrithione can increase the level of intracellular zinc. As MBNL3 contains zinc-finger domains, increased intracellular zinc can enhance MBNL3 binding to its substrates, thereby potentially enhancing its activity. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B is an inhibitor of CRM1-dependent nuclear export. If MBNL3 is exported from the nucleus via a CRM1-dependent mechanism, leptomycin B can enhance MBNL3 activity by increasing its nuclear retention, which may allow for increased interaction with nuclear substrates. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline can induce conformational changes in certain proteins. If MBNL3 undergoes a conformational change upon tetracycline binding, this could potentially enhance its activity by facilitating substrate binding. | ||||||